Indegene Limited INDGN.NS · Stock Open Indegene Limited in new tab
Indegene Limited Analysis (INDGN.NS)
Is Indegene Limited a good investment? Indegene Limited (INDGN.NS) is currently trading at 508.05 INR. Market analysts have a consensus price target of 605.29 INR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 30.61. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Indegene Limited is expected to release its next earnings report on July 30, 2026. The market consensus estimate for Forward EPS is 26.65.
Investor FAQ
Does Indegene Limited pay a dividend?
No, it does not currently pay a dividend.
What asset class is Indegene Limited?
Indegene Limited is classified as a Stock.
When is the next earnings date?
The next earnings date is projected to be July 30, 2026. The company currently has a trailing EPS of 16.60.
Company Profile
Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms. Further, it provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India.
| Year | Total Dividends |
|---|---|
| ▸2026 |
2.25 INR
|
| July 31, 2026 | 2.2500 |
| ▸2025 |
2.00 INR
|
| July 26, 2025 | 2.0000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Indegene Limited | Jul 31, 2026 | Upcoming | 2.25 INR |
Community Discussion